Portfolio
/
Optibrium
Discovering the intersection of Technology and Life Sciences
Watch
Portfolio
/
Optibrium
Watch
Optibrium provides pharma and biotech companies with cutting edge drug discovery software solutions, offering a broad range of products including AI-enabled predictive tools. The business operates a subscription revenue model with excellent customer retention metrics and services a global customer base. Drug discovery software is a rapidly growing market driven by the imperative to increase speed and reduce cost in the identification of potential new drug candidates.
By investing significantly in R&D capability, Optibrium has accelerated the roll-out of new and enhanced software product and features
Optibrium’s Cerella solution is a proven AI-powered drug discovery software solution offering a unique proposition in a complex field
By investing in people, process and software tools, the business has materially grown its sales & marketing capability
Other stats
